SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Sick Visit — John Locke
| Patient | John Locke |
|---|
| Date of birth | 1966-09-08 |
|---|
| Identifiers | MRN HR-EN001-SYN; SSN (made up) 000-01-8305 |
|---|
| Document date | 2026-10-08 |
|---|
| Author | Prudence Hartwell-Osei, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Chief Complaint
A cold for three days, now with cough, wheeze, and a lower peak flow. [S]
History of Present Illness
Mr. Locke is a 60-year-old man with asthma and persistent airflow limitation on budesonide-formoterol maintenance and reliever therapy with tiotropium, who called this morning and was seen the same day. Three days ago he developed a sore throat and runny nose after a houseguest's cold; since yesterday he has had a cough, wheeze, and tightness, and woke twice last night. His home peak flow has been 290 to 310 L/min against a personal best of 440, the yellow zone of his action plan. Following the plan, he has taken five or six extra inhalations of budesonide-formoterol a day on top of his four maintenance inhalations, never more than 12 in a day, with relief for several hours each time. He has had a temperature of 37.6 C, no shaking chills, no chest pain, and no colored sputum. A home COVID-19 test yesterday was negative. He had this season's influenza, COVID-19, and RSV vaccines three weeks ago. [S]
| Element | Detail |
|---|
| Onset | Cold three days ago; chest symptoms since yesterday |
| Severity | Home peak flow 290 to 310 L/min (66 to 70 percent of best); woke twice last night |
| Treatment so far | Five or six extra budesonide-formoterol inhalations a day, within 12 a day; tiotropium continued |
| Pertinent negatives | No high fever, chest pain, colored sputum, or breathlessness at rest; home COVID-19 test negative |
Review of Systems
| System | Result | Finding |
|---|
| Constitutional | Positive | Low-grade temperature and tiredness; eating and drinking normally |
| Ears, nose, mouth, and throat | Positive | Sore throat and clear runny nose; no ear or facial pain |
| Respiratory | Positive | Cough, wheeze, and chest tightness; no hemoptysis or pleuritic pain |
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
4 systems reviewed. [S]
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Albuterol 90 mcg/actuation inhaler, two puffs every 4 hours as needed while tests are done; hold for 6 hours before spirometry | Two puffs every 4 hours as needed | Respiratory tract route | 2026-03-12 to 2026-03-26 | completed | S |
| Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 4): two inhalations twice daily and one inhalation as needed for symptoms, no more than 12 inhalations a day | Two inhalations twice daily plus one as needed; no more than 12 a day | Respiratory tract route | 2026-03-26 | active | S |
| Tiotropium 2.5 mcg/actuation soft-mist inhaler, two inhalations once daily (add-on long-acting muscarinic antagonist, GINA step 5) | Two inhalations once a day | Respiratory tract route | 2026-06-18 | active | S |
| Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for aches or fever, no more than 3 g a day | One or two tablets every 6 hours as needed; no more than six tablets a day | Oral route | 2026-10-08 to 2026-10-22 | completed | S |
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 2026-10-08 | Body height | 178 | cm | S |
| 2026-10-08 | Body weight | 62.6 | kg | S |
| 2026-10-08 | Body mass index (BMI) [Ratio] | 19.8 | kg/m2 | S |
| 2026-10-08 | Systolic blood pressure | 124 | mm[Hg] | S |
| 2026-10-08 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-10-08 | Heart rate | 94 | /min | S |
| 2026-10-08 | Respiratory rate | 20 | /min | S |
| 2026-10-08 | Body temperature | 37.6 | Cel | S |
| 2026-10-08 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-10-08 | Maximum expiratory gas flow Respiratory system airway by Peak flow meter | 300 | L/min | 80 percent of his personal best of 440 L/min | Low | S |
Physical Exam
Vital signs recorded on 2026-10-08; see the Vital Signs section. [S]
| System | Finding |
|---|
| General | Tired but comfortable; speaks in full sentences; no use of accessory muscles |
| Ears, nose, and throat | Clear nasal discharge; mild pharyngeal redness without exudate |
| Respiratory | Scattered expiratory wheeze throughout both lungs; no crackles or bronchial breathing; respiratory rate 20; oxygen saturation 95 percent |
| Cardiovascular | Heart rate 94, regular; no edema |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Chronic cough with wheeze and breathlessness since his late thirties, worse every winter and within a day of any stay in the city or by an open fire, better in warm weather and country air; night cough two or three times a week this winter; under evaluation | resolved | confirmed |
R05.3 | S — Synthetic presenting problem echoing his documented lifelong cough and breathlessness in London's coal smoke; superseded by the diagnosis at the second visit. |
| Long exposure to urban air pollution (decades in a large city with heavy traffic and coal and wood burning) and to indoor solid-fuel smoke from open coal and wood fires at home | active | confirmed |
Z77.110 | S — Synthetic modern exposure echoing the coal smoke that he, Sydenham, and Lady Masham blamed for his cough; no historical level of exposure is asserted. |
| Asthma with persistent airflow limitation, type 2 (eosinophilic) phenotype, in a never-smoker: post-bronchodilator FEV1/FVC 0.62, FEV1 62 percent predicted rising 380 mL after albuterol, FeNO 41 ppb, eosinophils 0.46 x 10^3/uL, IgE 186 IU/mL, normal DLCO, no emphysema on CT; aggravated by air pollution and indoor smoke; not COPD | active | confirmed |
J45.40 | S — Synthetic modern diagnosis. His lifelong cough and breathlessness worse in coal smoke are documented (D); calling them asthma is a modern retrospective reading (R). |
| Acute viral upper respiratory infection (common cold) with a yellow-zone asthma flare: peak flow 68 percent of personal best, managed with extra as-needed budesonide-formoterol by his action plan, without oral corticosteroids; resolved | active | confirmed |
J06.9 | S — Synthetic intercurrent illness at an unscheduled visit; it echoes, without asserting, his documented autumn chest troubles (CLM-0014). |
Assessment and Plan
- Acute viral upper respiratory infection with a yellow-zone asthma flare (J06.9). A cold that has triggered a mild flare: clinic peak flow 300 L/min (68 percent of his best), wheeze without signs of a severe attack, oxygen saturation 95 percent, and a good response to extra as-needed budesonide-formoterol. No sign of pneumonia, so no chest X-ray and no antibiotic, following ACP and CDC advice. He has followed his action plan correctly. [S]
- Continue maintenance inhalations and take extra budesonide-formoterol as needed, no more than 12 inhalations in a day.
- Continue tiotropium.
- Start prednisolone 40 mg daily for 5 days only if the peak flow falls below 264 L/min (60 percent of best), if he needs more than 12 inhalations a day, or if he is no better in 2 to 3 days; he will call the clinic first.
- Red zone (peak flow below 220 L/min, breathless at rest, or not helped by his inhaler): call 911.
- Acetaminophen for aches; honey and warm drinks for the cough; keep away from fires and smoky rooms.
- Asthma review in one week.
- Asthma with persistent airflow limitation (J45.40). Well controlled before this cold; the flare is the first since treatment began. [S]
- Action plan reviewed with him; peak flow twice daily until back to his best.
Guideline basis: CMID: Clinical Monitoring Intelligence Database, asthma and COPD monographs (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention (2016)
Follow-up: Asthma review in one week; sooner for the warning signs above. Next scheduled visit 2026-10-22: asthma review two weeks after a cold with a yellow-zone flare. [S]